Displaying 1 - 20 of 465
FTC Sends Refunds to Consumers Harmed by CafePress’s Data Security Failures
FTC Warns Companies to Stop Warranty Practices That Harm Consumers’ Right to Repair
FTC Issues Final Amendments to Amplifier Rule to Make Testing Methods More Useful to Consumers
FTC Sends Refunds to Consumers Harmed by False Made in USA Claims by Cycra
FTC Announces Tentative Agenda for March 21 Open Commission Meeting
FTC Action Leads to $2 Million Penalty Against Kubota for False Made in USA Claims
Vyera Pharmaceuticals, LLC
The Federal Trade Commission and a group of seven state enforcers filed a complaint in federal district court against Vyera Pharmaceuticals, LLC, alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug, Daraprim. The Commission vote to issue the complaint was 5-0. The complaint was filed on Jan. 27, 2020, in the U.S. District Court for the Southern District of New York. In a Jan. 14, 2022 ruling, U.S. District Court Judge Denise Cote found Shkreli’s conduct “egregious, deliberate, repetitive, long-running, and ultimately dangerous.” Judge Cote banned Shkreli for life from the pharmaceutical industry.
On January 23, 2024, the U.S. Court of Appeals for the Second Circuit affirmed the U.S. District Court for the Southern District of New York’s ruling.
FTC Finalizes Order Against Clothing Accessories Company for False Made in USA Claims
FTC Issues Supplemental Proposed Amendments to its Amplifier Rule to Make Testing Methods More Useful to Consumers
Cycra, Inc.
The Federal Trade Commission is taking action against motocross and ATV parts maker Cycra and its officer, Chad James, for falsely claiming that the company’s products were manufactured in the U.S. The FTC’s proposed order would stop Cycra and James from making deceptive claims about products being “Made in USA” and require them to pay a monetary judgment. In June 2023, the Commission announced the finalized order. In May 2024, the FTC sent $180,000 in refunds to consumers in this case.